Silence Therapeutics PLC
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -97.9% | -100.0% | – | +2,145.5% | +126.6% | +42.2% | +43.7% | +70.5% | -98.7% | |
| – | -19.9% | +22.4% | -8.8% | +22.7% | – | – | +98.2% | +47.2% | -6.0% | +14.5% | -98.2% | |
| – | – | – | – | – | – | +603.7% | +188.8% | +34.7% | +125.5% | +108.9% | -98.9% | |
| – | -19.9% | +22.4% | -8.8% | +22.7% | +36.9% | +51.5% | +52.2% | +15.4% | +24.0% | +54.2% | -0.2% | |
| – | -18.5% | +49.3% | +63.0% | +67.5% | -11.0% | +45.0% | +43.1% | +4.6% | -1.4% | +30.3% | -16.9% | |
| – | -18.5% | +49.3% | +63.0% | +67.5% | +112.2% | +63.5% | +35.2% | +11.2% | +14.6% | +46.6% | -4.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +131.3% | +354.1% | -99.0% | +200.0% | -26.7% | -51.5% | -50.0% | +487.5% | -27.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -1,355.8% | – | -98.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.